Gary Cunningham
Angel Investor
Gary Cunningham is a Series A investor focused on Medical and Hospital. At Results Physiotherapy, we are committed to having people who are passionate, who care about their work, who see it as a reflection of themselves. There are no unimportant people and no unimportant jobs in our organization.Before launching our business in Tennessee, I came to the field of physical therapy through an unconventional path. First Igraduated in Law from the University of Queensland in Australia. Then I moved up through a career in banking, law and university administration.It was when I became CEO of a healthcare company operating in Queensland and New South Wales that I began to meet highly qualified physical therapists. Some of these people had worked in the US, and they told me that skilled hands-on treatment was missing from US physical therapy. They said patient outcomes suffered as a result.After traveling to the US and conducting extensive market research, my partners and I recognized a compelling opportunity. In 1996, we opened our first Tennessee clinic with therapists trained in Australia, and since then, we’ve trained many new therapists in the practice of hands-on treatment combined with exercise. We’ve also documented significant improvements in patient outcomes, and our style of physical therapy is now considered the gold standard around the world. I know we’re making a difference, both to the young therapist we train and to the patients whose pain we relieve.We help people regain the use of their bodies and their lives, without unnecessary surgery and at less cost. Our therapists commit to rigorous professional standards and continuing education. As President and CEO, I want everyone who works with us to feel proud of what we do together and to gain a sense of personal validation. I want our patients and referral communities to feel completely confident that we deliver the most outstanding physical therapy available anywhere in the world.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Gary Cunningham invests in
Stages Gary Cunningham invests in
Countries Gary Cunningham invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Hospital 1 (100%)
- Software 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| DoseMe is unique decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations and genotype to guide dose optimisation. It’s the world’s first precision dosing tool designed for clinical practice that uses Bayesian dosing methods. Its simplicity and portability means Bayesiandosing benefits can be brought to every bedside. | $2.6M / Series A / Aug 25, 2016 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Gary Cunningham invest in?
Gary Cunningham invests primarily in Medical, Hospital and Software startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gary Cunningham?
Public channels for Gary Cunningham include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gary Cunningham last invest?
The most recent investment recorded for Gary Cunningham closed in Aug 2016. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
